Browse Articles

Discover research articles across all indexed journals

Man survives with titanium heart for 100 days — a world first

Nature Smriti Mallapaty Mar 27, 2025 DOI: 10.1038/d41586-025-00782-0

Asundexian versus Apixaban in Patients with Atrial Fibrillation

New England Journal of Medicine Mar 27, 2025 DOI: 10.1056/nejmc2501201

Health Care Bridges — Pathways toward Trust in Gaza and Beyond

New England Journal of Medicine Yasmeen Abu Fraiha, Abdalrahman Ahmed, Noam Alon et al. Mar 27, 2025 DOI: 10.1056/nejmp2416553

Beyond Glucocorticoids for IgG4-Related Disease

New England Journal of Medicine Robert Spiera Mar 27, 2025 DOI: 10.1056/nejme2413286

Inebilizumab for Treatment of IgG4-Related Disease

New England Journal of Medicine John H. Stone, Arezou Khosroshahi, Wen Zhang et al. Mar 27, 2025 DOI: 10.1056/nejmoa2409712

An ultra-broadband photonic-chip-based parametric amplifier

Nature Nikolai Kuznetsov, Alberto Nardi, Johann Riemensberger et al. Mar 27, 2025 DOI: 10.1038/s41586-025-08666-z

Abstract Optical amplification, crucial for modern communication, primarily relies on erbium-doped fibre amplifiers (EDFAs)1,2. Yet, EDFAs only cover a portion of the low-loss spectrum of optical fibres. This has motivated the development of amplifiers operating beyond the erbium gain window. Pioneering work on optical parametric amplifiers (OPAs)3,4 using intrinsic third-order optical nonlinearity has led to demonstrations of increased channel capacity. OPAs offer high gain, can reach the 3-dB quantum limit for phase-preserving amplifiers and exhibit unidirectional operation. However, power requirements for highly nonlinear fibres3,5–8 or bulk waveguides9,10 have impeded their adoption. By contrast, OPAs based on integrated photonic circuits offer the advantages of substantially increased mode confinement and optical nonlinearity but have been limited in bandwidth11,12. We overcome this challenge by using low-loss gallium phosphide-on-silicon dioxide13–15 photonic integrated circuits (PICs) and attain up to 35 dB of parametric gain with waveguides only a few centimetres long in a compact footprint of 0.25 square millimetres. Fibre-to-fibre net gain exceeding 10 dB across an ultra-broad bandwidth of approximately 140 nm (that is, 17 THz) is achieved, with a threefold increase in the gain window compared with C-band EDFAs. We further demonstrate a high dynamic range for input signals, spanning six orders of magnitude, while maintaining a low noise figure. We exploit these performance characteristics to amplify coherent communication signals. This marks, to our knowledge, the first ultra-broadband, high-gain, continuous-wave amplification in a photonic chip, opening up new capabilities for next-generation integrated photonics.

Unexplained or Refractory Chronic Cough in Adults

New England Journal of Medicine Richard S. Irwin, J. Mark Madison Mar 27, 2025 DOI: 10.1056/nejmra2309906

The Definition of Failure

New England Journal of Medicine Jason Gurney Mar 27, 2025 DOI: 10.1056/nejmp2414167

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

New England Journal of Medicine Komal L. Jhaveri, Patrick Neven, Monica Lis Casalnuovo et al. Mar 27, 2025 DOI: 10.1056/nejmoa2410858

Case 9-2025: A 59-Year-Old Man with Hepatocellular Carcinoma

New England Journal of Medicine Kathleen E. Corey, David M. Dudzinski, Alexander R. Guimaraes et al. Mar 27, 2025 DOI: 10.1056/nejmcpc1909622

Partnerships between Pharmaceutical and Telehealth Companies — Increasing Access or Driving Inappropriate Prescribing?

New England Journal of Medicine Erin C. Fuse Brown, Olivier J. Wouters, Ateev Mehrotra Mar 27, 2025 DOI: 10.1056/nejmp2500379

Nivolumab plus Ipilimumab in Advanced Melanoma

New England Journal of Medicine Mar 27, 2025 DOI: 10.1056/nejmc2501311

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation

New England Journal of Medicine Mar 27, 2025 DOI: 10.1056/nejmc2501560

Severe HDL Cholesterol Reduction with Bempedoic Acid and Fenofibrate

New England Journal of Medicine Francesco Sbrana, Federico Bigazzi, Beatrice Dal Pino Mar 27, 2025 DOI: 10.1056/nejmc2413726

Sézary Syndrome

New England Journal of Medicine Heloise Mazoyer, Claude Bachmeyer Mar 27, 2025 DOI: 10.1056/nejmicm2411990

Beta-Blocker Therapy after Acute Myocardial Infarction — To Block or Not to Block?

New England Journal of Medicine Christos P. Kotanidis, David J. Maron, Tomas Jernberg Mar 27, 2025 DOI: 10.1056/nejmclde2410735

BPROAD — End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes?

New England Journal of Medicine Shuchi Anand, Srinivasan Beddhu Mar 27, 2025 DOI: 10.1056/nejme2501656

Order out of Chaos

New England Journal of Medicine Eric J. Rubin Mar 27, 2025 DOI: 10.1056/nejme2502874

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps

New England Journal of Medicine Brian J. Lipworth, Joseph K. Han, Martin Desrosiers et al. Mar 27, 2025 DOI: 10.1056/nejmoa2414482

Author Correction: Observation of Nagaoka polarons in a Fermi–Hubbard quantum simulator

Nature Martin Lebrat, Muqing Xu, Lev Haldar Kendrick et al. Mar 27, 2025 DOI: 10.1038/s41586-025-08819-0